Elicera Therapeutics AB (publ) (STO: ELIC)
Sweden
· Delayed Price · Currency is SEK 1.750
+0.030 (1.74%)
Dec 27, 2024, 5:24 PM CET
Elicera Therapeutics AB Revenue
Elicera Therapeutics AB had revenue of 233.63K SEK in the quarter ending September 30, 2024, a decrease of -97.09%. This brings the company's revenue in the last twelve months to 4.29M, down -63.47% year-over-year. In the year 2023, Elicera Therapeutics AB had annual revenue of 11.23M with 777.23% growth.
Revenue (ttm)
4.29M
Revenue Growth
-63.47%
P/S Ratio
11.31
Revenue / Employee
2.14M
Employees
2
Market Cap
61.41M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 25.44B |
| Sectra AB | 3.14B |
| Getinge AB | 33.59B |
| Camurus AB | 1.69B |
| Vitrolife AB | 3.56B |
| Bonesupport Holding AB | 814.46M |
| Elekta AB | 17.72B |
| Vimian Group AB | 3.99B |